Triage Medical Staffing and TaleMed Merge

Triage Medical Staffing and TaleMed Merge

A pair of the nation’s largest healthcare staffing firms are merging. Ohama, Nebraska-based Triage Medical Staffing is acquiring TaleMed, LLC, creating one of the nation’s largest dual-threat Nursing and Allied Health recruitment agencies. No terms were disclosed, but the combined company is expected to have $200 million in annual revenues. TaleMed provides contingent staffing solutions to healthcare systems and hospitals nationwide through direct contract relationships and is consistently rated as one of the top travel healthcare companies. The company is also a top-tier provider with many prominent managed service providers. In recent years, Triage has experienced accelerated... Read More »
MOB Deals Accelerate in the Third Quarter

MOB Deals Accelerate in the Third Quarter

Medical office building (MOB) transactions have been flowing steadily throughout the third quarter, with 11 deals on the books so far according to DSO. Most deals are focused on facilities in the Southeastern region of the United States, such as Alabama, North and South Carolina, and Georgia, and the buyers are a mix of REITs, private real estate investment firms, and developers. So far in the third quarter, over 376,000 square feet of MOBs have been sold, with disclosed prices totaling approximately $113.6 million. Unlike other sectors in healthcare, MOBs seem to have benefited from a COVID-19 environment, as noted by JLL ( NYSE: JLL) in a report published in July. The COVID-19 pandemic... Read More »
CRO M&A Market in 2020 (So Far)

CRO M&A Market in 2020 (So Far)

There haven’t been many deals targeting contract research organizations (CRO) in 2020, especially compared to previous years, which makes sense. Life science companies are all slowing down clinical trials (COVID-19 vaccine research excluded) to adhere to social distancing guidelines, meaning CRO services are just not in as high demand. For 2020, only 10% of deals in the Other Services sector have targeted a CRO company (14 deals). To put that in context, CROs were targeted in 15% (29 transactions) of deals in the Other Services sector for 2019, according to The 2020 Health Care Services Acquisition Report. There haven’t been many headline deals this year for the CRO market.... Read More »
CRO M&A Market in 2020 (So Far)

Corizon Health Acquired by Global Investment Firm

A leading provider of correctional healthcare services is now under new management. Flacks Group, a privately held global investment firm, announced on June 30 it was acquiring Corizon Health Inc. for an undisclosed amount.   Corizon Health has provided evidence-based healthcare services to states and municipalities across the country for more than 40 years. Corizon offers comprehensive solutions for medical care, behavioral care, pharmaceutical, and re-entry services. Corizon Health’s PharmaCorr is the only in-house pharmacy in the corrections industry. The company employs over 5,000 staff, including doctors, nurses, and other healthcare professionals.  The acquisition accelerates Flacks... Read More »
MOB Deals Accelerate in the Third Quarter

REIT Deals are Still Closing Despite COVID-19

Despite COVID-19 taking a hit on REIT stocks and earnings, especially in the senior care industry, some buyers managed to close deals in May, primarily for medical office buildings. This might come as a surprise since physician practices are getting hit especially hard by COVID-19, so these deals may have been in the works before the pandemic crashed into the economy, or real estate values are running cheap. Just this week, Anchor Health Properties, a full-service real estate development, management, and investment company focused on healthcare property, announced its purchase of the Walther Professional Center, an 18,471-square-foot medical office building located close to Northside... Read More »
Parthenon Capital Sponsors RxSense

Parthenon Capital Sponsors RxSense

Parthenon Capital added to its growing list of healthcare companies with its recent “significant” investment in RxSense, a healthcare technology company offering prescription savings plans to consumers and pharmacy benefit services and analytics to enterprise customers. Proceeds from the transaction will be used for various growth initiatives. Terms of the investment were not disclosed. Boston-based RxSense and its direct-to-consumer division combine its proprietary technology platform with direct contracts with the nation’s largest pharmacies and extensive consumer engagement tools, to deliver low prices on prescription drugs. Its consumer prescription savings plans deliver... Read More »